Use access key #2 to skip to page content.
$51.05 0.00 (0.00%)
5/27/2008 4:00 PM

LifeCell Corp (LIFC.DL)

CAPS Rating:
No stars

The Company develops and markets tissue-based products for use in reconstructive, orthopedic and urogynecologic surgical procedures to repair soft tissue defects.

View All Commentary (LIFC.DL)

Recs

2

Avatar TyroJ (91.56) Submitted: 1/21/07 8:38 PM : Outperform Start Price: $24.39 LIFC.DL Score: 112.39

Good market to be in right now. This company was oversold on its last reporting due to investor fear, but should see a healthy rise up to its next earnings announcement. A definite short term hold until then.

Report this Post Replies: 0 | Reply

Featured Broker Partners